Works matching AU Keefe, Richard S. E.

Results: 70
    1

    Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial.

    Published in:
    Neuropsychopharmacology, 2006, v. 31, n. 9, p. 2033, doi. 10.1038/sj.npp.1301072
    By:
    • Keefe, Richard S. E.;
    • Bilder, Robert M.;
    • Harvey, Philip D.;
    • Davis, Sonia M.;
    • Palmer, Barton W.;
    • Gold, James M.;
    • Meltzer, Herbert Y.;
    • Green, Michael F.;
    • Miller, Del D.;
    • Canive, Jose M.;
    • Adler, Lawrence W.;
    • Manschreck, Theo C.;
    • Swartz, Marvin;
    • Rosenheck, Robert;
    • Perkins, Diana O.;
    • Walker, Trina M.;
    • Stroup, T. Scott;
    • McEvoy, Joseph P.;
    • Lieberman, Jeffrey A.
    Publication type:
    Article
    2
    3

    Insight in first-episode psychosis.

    Published in:
    Psychological Medicine, 2006, v. 36, n. 10, p. 1385, doi. 10.1017/S0033291706007793
    By:
    • JOSEPH P. McEVOY;
    • JACKIE JOHNSON;
    • DIANA PERKINS;
    • JEFFREY A. LIEBERMAN;
    • ROBERT M. HAMER;
    • RICHARD S. E. KEEFE;
    • MAURICIO TOHEN;
    • IRA D. GLICK;
    • TONMOY SHARMA
    Publication type:
    Article
    4
    5
    6

    Batería Cognitiva de Consenso MATRICS, parte 1: selección de pruebas, fiabilidad y validez.

    Published in:
    American Journal of Psychiatry - Edición Española, 2008, v. 11, n. 5, p. 284
    By:
    • Nuechterlein, Keith H.;
    • Green, Michael F.;
    • Kern, Robert S.;
    • Baade, Lyle E.;
    • Barch, Deanna M.;
    • Cohen, Jonathan D.;
    • Essock, Susan;
    • Fenton, Wayne S.;
    • Frese, Frederick J.;
    • Gold, James M.;
    • Goldberg, Terry;
    • Heaton, Robert K.;
    • Keefe, Richard S. E.;
    • Kraemer, Helena;
    • Mesholam-Gately, Raquelle;
    • Seidman, Larry J.;
    • Stover, Ellen;
    • Weinberger, Daniel R.;
    • Young, Alexander S.;
    • Zalcman, Steven
    Publication type:
    Article
    7
    8
    9

    Commentary.

    Published in:
    Schizophrenia Bulletin, 2025, v. 51, n. 2, p. 278, doi. 10.1093/schbul/sbae191
    By:
    • Keefe, Richard S E
    Publication type:
    Article
    10
    11

    Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial.

    Published in:
    Schizophrenia Bulletin, 2019, v. 45, n. 2, p. 350, doi. 10.1093/schbul/sby049
    By:
    • Brown, David;
    • Nakagome, Kazuyuki;
    • Cordes, Joachim;
    • Brenner, Ronald;
    • Gründer, Gerhard;
    • Keefe, Richard S E;
    • Riesenberg, Robert;
    • Walling, David P;
    • Daniels, Kristen;
    • Wang, Lara;
    • McGinniss, Jennifer;
    • Sand, Michael
    Publication type:
    Article
    12
    13
    14
    15

    Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia.

    Published in:
    Neuropsychopharmacology, 2011, v. 36, n. 3, p. 616, doi. 10.1038/npp.2010.193
    By:
    • McClay, Joseph L.;
    • Adkins, Daniel E.;
    • Åberg, Karolina;
    • Bukszár, Jozsef;
    • Khachane, Amit N.;
    • Keefe, Richard S. E.;
    • Perkins, Diana O.;
    • McEvoy, Joseph P.;
    • Stroup, T. Scott;
    • Vann, Robert E.;
    • Beardsley, Patrick M.;
    • Lieberman, Jeffrey A.;
    • Sullivan, Patrick F.;
    • Van den Oord, Edwin J. C. G.
    Publication type:
    Article
    16
    17
    18

    Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia.

    Published in:
    Neuropsychopharmacology, 2009, v. 34, n. 8, p. 1885, doi. 10.1038/npp.2009.26
    By:
    • Marx, Christine E.;
    • Keefe, Richard S. E.;
    • Buchanan, Robert W.;
    • Hamer, Robert M.;
    • Kilts, Jason D.;
    • Bradford, Daniel W.;
    • Strauss, Jennifer L.;
    • Naylor, Jennifer C.;
    • Payne, Victoria M.;
    • Lieberman, Jeffrey A.;
    • Savitz, Adam J.;
    • Leimone, Linda A.;
    • Dunn, Lawrence;
    • Porcu, Patrizia;
    • Morrow, A. Leslie;
    • Shampine, Lawrence J.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Report on ISCTM Consensus Meeting on Clinical Assessment of Response to Treatment of Cognitive Impairment in Schizophrenia.

    Published in:
    Schizophrenia Bulletin, 2016, v. 42, n. 1, p. 19, doi. 10.1093/schbul/sbv111
    By:
    • Keefe, Richard S. E.;
    • Haig, George M.;
    • Marder, Stephen R.;
    • Harvey, Philip D.;
    • Dunayevich, Eduardo;
    • Medalia, Alice;
    • Davidson, Michael;
    • Lombardo, Ilise;
    • Bowie, Christopher R.;
    • Buchanan, Robert W.;
    • Bugarski-Kirola, Dragana;
    • Carpenter, William T.;
    • Csernansky, John T.;
    • Dago, Pedro L.;
    • Durand, Dante M.;
    • Frese, Frederick J.;
    • Goff, Donald C.;
    • Gold, James M.;
    • Hooker, Christine I.;
    • Kopelowicz, Alex
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Methodological Issues in Negative Symptom Trials.

    Published in:
    Schizophrenia Bulletin, 2011, v. 37, n. 2, p. 250, doi. 10.1093/schbul/sbq161
    By:
    • Marder, Stephen R.;
    • Daniel, David G.;
    • Alphs, Larry;
    • Awad, A. George;
    • Keefe, Richard S. E.
    Publication type:
    Article
    50